HyperChildNET COST Action CA19115: report of the task force
Purpose: Despite dramatic medical advances over the last few decades, cardiovascular disease remains a leading cause of death globally. High BP is clearly established, but modifiable, risk factor for early disability and death. Although most of the adverse outcomes occur in adulthood it has become c...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Blood Pressure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/08037051.2024.2421214 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850058640489185280 |
|---|---|
| author | E. Lurbe G. Mancia D. Drozdz S. Erdine F. Fernandez-Aranda M. Litwin M. D. Sinha G. Simonetti S. Stabouli E. Wühl |
| author_facet | E. Lurbe G. Mancia D. Drozdz S. Erdine F. Fernandez-Aranda M. Litwin M. D. Sinha G. Simonetti S. Stabouli E. Wühl |
| author_sort | E. Lurbe |
| collection | DOAJ |
| description | Purpose: Despite dramatic medical advances over the last few decades, cardiovascular disease remains a leading cause of death globally. High BP is clearly established, but modifiable, risk factor for early disability and death. Although most of the adverse outcomes occur in adulthood it has become clear that high BP is a life course problem that can become evident in early life however, relatively little attention has been paid to the problem of high BP in children and adolescents. Materials and methods: Being aware of the problem and the needs, the Task Force of the ESH Guidelines in children and adolescents took the initiative to move forward in the field, identifying the COST Action program. A proposal, HyperChildNET, was submitted, approved and funded for 4 years starting in October 2020. Results: The aim of the Action has been to establish a European sustainable and multidisciplinary network of researchers, clinicians, early career investigators, health economists, decision-makers, regulatory bodies, and medical devices manufacturers under the umbrella of the European Commission in order to acquire a holistic understanding of those factors affecting high BP in children and adolescents in order to propose and implement preventive and corrective actions. All the activities carried out during the 4 years are described. Conclusions: HyperChildNET offers a European perspective of the issue giving us the opportunity to develop new strategies and objectives moving forward in the field. |
| format | Article |
| id | doaj-art-7bbda520672d4cc7a712c0557638e8ed |
| institution | DOAJ |
| issn | 0803-7051 1651-1999 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Blood Pressure |
| spelling | doaj-art-7bbda520672d4cc7a712c0557638e8ed2025-08-20T02:51:06ZengTaylor & Francis GroupBlood Pressure0803-70511651-19992024-12-0133110.1080/08037051.2024.2421214HyperChildNET COST Action CA19115: report of the task forceE. Lurbe0G. Mancia1D. Drozdz2S. Erdine3F. Fernandez-Aranda4M. Litwin5M. D. Sinha6G. Simonetti7S. Stabouli8E. Wühl9CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, SpainDepartment of Pediatrics, University of Milano-Bicocca, Milan, ItalyDepartment of Pediatric Nephrology and Hypertension, Pediatric Institute, Jagiellonian University Medical College, Kraków, PolandUniversity of Istanbul Cerrahpasa School of Medicine, Istanbul, TurkeyCIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, SpainDepartment of Nephrology, Kidney Transplantation and Hypertension, The Children’s Memorial Health Institute, Warsaw, PolandDepartment of Paediatric Nephrology, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust, Kings College London, London, UKInstitute of Pediatrics of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland1st Department of Pediatrics, Aristotle University of Thessaloniki, Hippokratio General Hospital of Thessaloniki, Thessaloniki, GreeceMedical Faculty Heidelberg, Center for Pediatrics and Adolescent Medicine, Division of Pediatric Nephrology, Heidelberg University, Heidelberg, GermanyPurpose: Despite dramatic medical advances over the last few decades, cardiovascular disease remains a leading cause of death globally. High BP is clearly established, but modifiable, risk factor for early disability and death. Although most of the adverse outcomes occur in adulthood it has become clear that high BP is a life course problem that can become evident in early life however, relatively little attention has been paid to the problem of high BP in children and adolescents. Materials and methods: Being aware of the problem and the needs, the Task Force of the ESH Guidelines in children and adolescents took the initiative to move forward in the field, identifying the COST Action program. A proposal, HyperChildNET, was submitted, approved and funded for 4 years starting in October 2020. Results: The aim of the Action has been to establish a European sustainable and multidisciplinary network of researchers, clinicians, early career investigators, health economists, decision-makers, regulatory bodies, and medical devices manufacturers under the umbrella of the European Commission in order to acquire a holistic understanding of those factors affecting high BP in children and adolescents in order to propose and implement preventive and corrective actions. All the activities carried out during the 4 years are described. Conclusions: HyperChildNET offers a European perspective of the issue giving us the opportunity to develop new strategies and objectives moving forward in the field.https://www.tandfonline.com/doi/10.1080/08037051.2024.2421214Childrenadolescentshypertensionblood pressureHyperChildNETCOST Action |
| spellingShingle | E. Lurbe G. Mancia D. Drozdz S. Erdine F. Fernandez-Aranda M. Litwin M. D. Sinha G. Simonetti S. Stabouli E. Wühl HyperChildNET COST Action CA19115: report of the task force Blood Pressure Children adolescents hypertension blood pressure HyperChildNET COST Action |
| title | HyperChildNET COST Action CA19115: report of the task force |
| title_full | HyperChildNET COST Action CA19115: report of the task force |
| title_fullStr | HyperChildNET COST Action CA19115: report of the task force |
| title_full_unstemmed | HyperChildNET COST Action CA19115: report of the task force |
| title_short | HyperChildNET COST Action CA19115: report of the task force |
| title_sort | hyperchildnet cost action ca19115 report of the task force |
| topic | Children adolescents hypertension blood pressure HyperChildNET COST Action |
| url | https://www.tandfonline.com/doi/10.1080/08037051.2024.2421214 |
| work_keys_str_mv | AT elurbe hyperchildnetcostactionca19115reportofthetaskforce AT gmancia hyperchildnetcostactionca19115reportofthetaskforce AT ddrozdz hyperchildnetcostactionca19115reportofthetaskforce AT serdine hyperchildnetcostactionca19115reportofthetaskforce AT ffernandezaranda hyperchildnetcostactionca19115reportofthetaskforce AT mlitwin hyperchildnetcostactionca19115reportofthetaskforce AT mdsinha hyperchildnetcostactionca19115reportofthetaskforce AT gsimonetti hyperchildnetcostactionca19115reportofthetaskforce AT sstabouli hyperchildnetcostactionca19115reportofthetaskforce AT ewuhl hyperchildnetcostactionca19115reportofthetaskforce |